| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 20 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 20 |
| 2 | TACROLIMUS OINTMENT 0.1% | 20 |
| 3 | MYCOPHENOLATE MOFETIL | 17 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 17 |
| 5 | PREDNISONE | 17 |
| 6 | METHYLPREDNISOLONE | 9 |
| 7 | PEMBROLIZUMAB | 7 |
| 8 | PREDNISOLONE | 7 |
| 9 | PREDNISOLONE ORAL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0008 |
| 1 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0008 |
| 2 | BELATACEPT | 3 | 0.0006 |
| 3 | NERANDOMILAST | 1 | 0.0006 |
| 4 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 1 | 0.0006 |
| 5 | FLUVOXAMINE MALEATE | 1 | 0.0004 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| 7 | GADODIAMIDE | 1 | 0.0003 |
| 8 | IDELALISIB | 2 | 0.0003 |
| 9 | LABETALOL | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 2 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 3 | 0.0001 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 7 | 0.0001 |
| 9 | Anticholinergic [EPC] | 1 | 0.0001 |